Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lomon

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Medecine Et Maladies Infectieuses|December 29, 2004
[Acute exacerbation of chronic bronchitis: patients, antibiotherapy, and guidelines]J Gaillat, I Duprat-Lomon, N Mortier
Clinical Drug Investigation|February 2, 2012
Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysisWilma Erhardt, Klas Bergenheim, Isabelle Duprat-Lomon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 18, 2003
Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profileHelen Doll, Isabelle Duprat-Lomon, Erika Ammerman, et al.
Autophagy|April 26, 2013
Reciprocal effects of rab7 deletion in activated and neglected T cellsSaurabh Ghosh Roy, Michael W Stevens, Lomon So, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 7, 2002
[Characteristics and predictive value of quality of life in a French cohort of angina patients]S M Consoli, L Guize, P Ducimetière, et al.
Diabetes Technology & Therapeutics|November 10, 2011
The cost-effectiveness of saxagliptin versus NPH insulin when used in combination with other oral antidiabetes agents in the treatment of type 2 diabetes mellitus in PolandWladyslaw Grzeszczak, Leszek Czupryniak, Katarzyna Kolasa, et al.
Diabetology & Metabolic Syndrome|July 10, 2014
A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapyMichelle Orme, Peter Fenici, Isabelle Duprat Lomon, et al.
Thorax|February 2, 2006
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitisR Wilson, P Jones, T Schaberg, et al.
Chest|September 13, 2002
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumoniaDonna L Lamping, Sara Schroter, Patrick Marquis, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 2001
[Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study]P Amouyel, M Farnier, G Lyon, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Medecine Et Maladies Infectieuses|December 29, 2004
[Acute exacerbation of chronic bronchitis: patients, antibiotherapy, and guidelines]J Gaillat, I Duprat-Lomon, N Mortier
Clinical Drug Investigation|February 2, 2012
Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysisWilma Erhardt, Klas Bergenheim, Isabelle Duprat-Lomon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 18, 2003
Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profileHelen Doll, Isabelle Duprat-Lomon, Erika Ammerman, et al.
Autophagy|April 26, 2013
Reciprocal effects of rab7 deletion in activated and neglected T cellsSaurabh Ghosh Roy, Michael W Stevens, Lomon So, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 7, 2002
[Characteristics and predictive value of quality of life in a French cohort of angina patients]S M Consoli, L Guize, P Ducimetière, et al.
Diabetes Technology & Therapeutics|November 10, 2011
The cost-effectiveness of saxagliptin versus NPH insulin when used in combination with other oral antidiabetes agents in the treatment of type 2 diabetes mellitus in PolandWladyslaw Grzeszczak, Leszek Czupryniak, Katarzyna Kolasa, et al.
Diabetology & Metabolic Syndrome|July 10, 2014
A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapyMichelle Orme, Peter Fenici, Isabelle Duprat Lomon, et al.
Thorax|February 2, 2006
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitisR Wilson, P Jones, T Schaberg, et al.
Chest|September 13, 2002
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumoniaDonna L Lamping, Sara Schroter, Patrick Marquis, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 2001
[Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study]P Amouyel, M Farnier, G Lyon, et al.
Pageof 5